- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01182545
The Effects of Hyperventilation Prior to CO2 Insufflation During Laparoscopic Cholecystectomy
A Prospective Randomized Study of the Effects of Hyperventilation Prior to Carbon Dioxide Insufflation on Hemodynamic Changes During Laparoscopic Cholecystectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The use of laparoscopic techniques has become common in clinical practice. Absorption of carbon dioxide (CO2) from the peritoneal cavity is the potential mechanism for hypercapnia and a rise in the end-tidal carbon dioxide (EtCO2). Mild hypercarbia causes sympathetic stimulation which results in a fivefold increase in arginine vasopressin (AVP), tachycardia, increased systemic vascular resistance, systemic arterial pressure, central venous pressure and cardiac output.1 Severe hypercarbia exerts a negative inotropic effect on the heart and reduces left ventricular function.2 Hemodynamic alterations occur only when the PaCO2 is increased by 30 per cent above the normal levels.
Clearance of CO2 is a function of the adequacy of alveolar ventilation with respect to pulmonary perfusion. Controlled hyperventilation has proved to be superior over spontaneous respiration or controlled normo-ventilation for maintaining normal PCO2 during laparoscopy. During pelvic laparoscopy there was a rapid rise of about 30% in the CO2 load eliminated by the lungs. This quickly reached a plateau and could be compensated by hyperventilation of the lungs with a 30% increase in minute ventilation.
Papadimitriou and co' workers concluded that under sevoflurane anesthesia MAC, prophylactic hyperventilation to ensure mild hypocapnia, (around 33 mmHg) limits the cerebral blood flow velocities enhancing effect of CO2 insufflation, compared with permissive hypercapnia (up to 45 mmHg), during gynecological laparoscopies. However, others advocated that hyperventilation and the head-up position before CO2 insufflation are not sufficient to prevent the CO2-mediated cerebral hemodynamic effects of low-pressure pneumoperitoneum (5-8 mmHg) in children, underwent laparoscopic fundoplication.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Eastern
-
Al Khubar, Eastern, Saudi Arabia, 31952
- King Faisal University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASA I & II
- aged 18-45 years
- undergoing elective laparoscopic cholecystectomy
Exclusion Criteria:
- history of cardiovascular disease
- respiratory diseases
- neurological disease
- renal disease
- liver disease
- hormonal disease
- pregnancy
- obesity (defined as a body mass index> 29)
- smokers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: The normoventilation group
15 minutes prior to CO2 insufflation, the patients' lungs were ventilated with a tidal volume (TV) of about 8 mL.kg-1 and respiratory rate (R.R) owas adjusted to maintain an end-tidal CO2 (ETCO2) of 4.6-6 kPa throughout the procedure.
|
Mechanical ventilation was conducted in all the patients with a Datex-Ohmeda Aestiva/5 Smart Ventilator (Madison, WI) through a rebreathing circuit incorporating a CO2 absorber, a heat and moisture exchanger using volume-controlled mode with an inspiratory to expiratory ratio of 1:2.5, and positive end-expiratory pressure (PEEP) of 5 cm H2O.
Plateau pressure was kept as low as possible with an upper limit of 30 cm H2O, and the absence of auto-PEEP was ensured by a drop of the expiratory flow to zero on the flow-time curve.
|
Active Comparator: The hyperventilation group
15 minutes prior to CO2 insufflation, the patients' lungs were ventilated with a TV of 8 mL.kg-1 with the adjustment of the R.R to maintain an ETCO2 of 4-4.6 kPa, until the end of anaesthesia.
|
Mechanical ventilation was conducted in all the patients with a Datex-Ohmeda Aestiva/5 Smart Ventilator (Madison, WI) through a rebreathing circuit incorporating a CO2 absorber, a heat and moisture exchanger using volume-controlled mode with an inspiratory to expiratory ratio of 1:2.5, and positive end-expiratory pressure (PEEP) of 5 cm H2O.
Plateau pressure was kept as low as possible with an upper limit of 30 cm H2O, and the absence of auto-PEEP was ensured by a drop of the expiratory flow to zero on the flow-time curve.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
haemodynamic percussion response
Time Frame: at 5 and 10 minutes, in supine and Trendelenburg (30° head-down) positions, respectively, before CO2 insufflation and at 15, 30, 45, and 60 min after CO2 insufflation, and at 5 min after desufflation of pneumoperitoneum
|
changes in mean arterial blood pressure [MAP] and heart rate [H.R].
|
at 5 and 10 minutes, in supine and Trendelenburg (30° head-down) positions, respectively, before CO2 insufflation and at 15, 30, 45, and 60 min after CO2 insufflation, and at 5 min after desufflation of pneumoperitoneum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
other hemodynamic and respiratory parameters
Time Frame: at 5 and 10 minutes, in supine and Trendelenburg (30° head-down) positions, respectively, before CO2 insufflation and at 15, 30, 45, and 60 min after CO2 insufflation, and at 5 min after desufflation of pneumoperitoneum,
|
systemic vascular resistance index (SVRI), cardiac index (CI), stroke volume index (SVI), PaCO2, EtCO2, arterial to end-tidal CO2 gradient (Pa-EtCO2), respiratory rate and airway pressures were recorded.
|
at 5 and 10 minutes, in supine and Trendelenburg (30° head-down) positions, respectively, before CO2 insufflation and at 15, 30, 45, and 60 min after CO2 insufflation, and at 5 min after desufflation of pneumoperitoneum,
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Mohamed R El Tahan, M.D., King Faisal University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-10-2007
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopic Cholecystectomy
-
Wake Forest University Health SciencesAmerican College of SurgeonsCompletedCholecystectomy, Laparoscopic | Appendectomy, Laparoscopic | Cholecystectomy, RoboticUnited States
-
Clinical Research Centre, MalaysiaCompletedComplication Laparoscopic Cholecystectomy | Conversion Laparoscopic to Open CholecystectomyMalaysia
-
Intuitive SurgicalRecruitingLaparoscopic Cholecystectomy | Robotic-assisted CholecystectomyUnited States
-
Mohamed Bakr Mohamed AhmedNot yet recruitingLaparoscopic Cholecystectomy
-
Mansoura UniversityCompletedLaparoscopic CholecystectomyEgypt
-
Acibadem UniversityCompleted
-
Prisma Health-UpstateCompleted
-
Seoul National University Bundang HospitalCompletedCholecystectomy, LaparoscopicKorea, Republic of
-
Banaras Hindu UniversityCompletedCholecystectomy, Laparoscopic
Clinical Trials on Ventilation
-
University of AarhusCompletedSleep | Environmental Exposure | Cognitive Impairment, MildDenmark
-
Xuzhou Medical UniversityUnknownInflammation | Thoracic Surgery | Pulmonary ComplicationChina
-
Shanghai Ninth People's Hospital Affiliated to...Unknown
-
Shanghai Zhongshan HospitalCompleted
-
Joseph D. TobiasCompleted
-
National Taiwan University HospitalRecruiting
-
Fundació Institut de Recerca de l'Hospital de la...WithdrawnObesity Hypoventilation Syndrome (OHS) | Chest Wall Disorders | Neuromuscular DisordersSpain
-
United States Army Institute of Surgical ResearchTerminated
-
Hospices Civils de LyonRecruitingPneumonia | Acute Respiratory Distress Syndrome | COVID19 | Sars-CoV2France
-
Boston Medical CenterWallace H. Coulter FoundationTerminated